Enablex 7.5 mg (Darifenacin (Darifenacin Hydrobromide) TABLET (EXTENDED-RELEASE)) 7.5 MG

ENABLEX 7.5 MG is an extended-release tablet containing darifenacin, used to manage overactive bladder symptoms. This medication helps control bladder contractions, improving urinary frequency and urgency. Learn more about ENABLEX 7.5 MG for bladder control.

Strength

7.5 MG

Pack Size

7/28

Manufacturer / TM Owner

SEARCHLIGHT PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ENABLEX 7.5 MG is primarily used to treat symptoms of overactive bladder, such as urinary urgency, frequency, and incontinence. Darifenacin, the active ingredient, works by relaxing the bladder muscle, reducing the sudden need to urinate. This medication is often prescribed for individuals experiencing bladder control issues, helping to improve quality of life.

Side Effects

Common effects of ENABLEX 7.5 MG may include dry mouth, constipation, and blurred vision. Some users might experience dizziness or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

ENABLEX 7.5 MG should be handled with care, especially by individuals with certain medical conditions like glaucoma or urinary retention. It is important to follow the prescribed dosage and avoid activities requiring mental alertness until you know how the medication affects you. Store the tablets in a cool, dry place away from children.

Avoid Interactions

ENABLEX 7.5 MG may interact with other medications, particularly those that affect the central nervous system or cause drowsiness. Alcohol should be avoided as it can enhance the sedative effects. Always inform your healthcare provider about all medications you are taking to prevent potential interactions.

Frequently Asked Questions

ENABLEX 7.5 MG is used to manage symptoms of overactive bladder, such as urinary urgency and frequency.

Darifenacin relaxes the bladder muscle, helping to control bladder contractions and reduce urinary urgency.

Common side effects may include dry mouth, constipation, and blurred vision. Dizziness and headaches are also possible.

It is advisable to avoid alcohol while taking ENABLEX 7.5 MG, as it can enhance the sedative effects of the medication.

Store ENABLEX 7.5 MG tablets in a cool, dry place, away from children and direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.